Acute lymphoblastic leukemia

Search Trials
Muscle Dysfunction in Patients With Haematological Diseases
Status:
Recruiting
Last Changed:
Dec 9, 2021
First Changed:
Dec 9, 2021
Disease(s):
Hematologic Diseases
Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL
Status:
Not yet recruiting
Last Changed:
Nov 10, 2021
First Changed:
Nov 10, 2021
Disease(s):
Lymphoma Leukemia
Intervention(s):
allogeneic CAR19 regulatory T cells (CAR19-tTreg)
Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL
Status:
Not yet recruiting
Last Changed:
Nov 10, 2021
First Changed:
Nov 10, 2021
Disease(s):
Lymphoma Leukemia
Intervention(s):
allogeneic CAR19 regulatory T cells (CAR19-tTreg)
Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma
Status:
Recruiting
Last Changed:
Dec 29, 2021
First Changed:
Dec 30, 2020
Disease(s):
T-cell Leukemia/Lymphoma
Intervention(s):
chimeric antigen receptor T cell treatment
Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma
Status:
Recruiting
Last Changed:
Dec 29, 2021
First Changed:
Dec 30, 2020
Disease(s):
T-cell Leukemia/Lymphoma
Intervention(s):
chimeric antigen receptor T cell treatment

Connect. Empower. Inspire.